Surgical Treatment of Carotid Body Paragangliomas: Outcomes and Complications According to the Shamblin Classification.
- Author:
Jae Yol LIM
1
;
Jinna KIM
;
Sun Ho KIM
;
Sak LEE
;
Young Chang LIM
;
Jae Wook KIM
;
Eun Chang CHOI
Author Information
- Publication Type:Original Article
- Keywords: Carotid body tumor; Paraganglioma
- MeSH: Carotid Artery, Internal; Carotid Body; Carotid Body Tumor; Cranial Nerves; Demography; Follow-Up Studies; Humans; Ischemic Attack, Transient; Length of Stay; Ligation; Medical Records; Paraganglioma; Recurrence; Stroke
- From:Clinical and Experimental Otorhinolaryngology 2010;3(2):91-95
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVES: The objective of this study was to review our experience in the surgical management of carotid body paragangliomas and evaluate the outcomes and complications according to the Shamblin classification. METHODS: Thirteen patients who had been diagnosed and surgically treated for carotid body tumors (CBTs) were enrolled in this study. We reviewed patient demographics, radiographic findings, and surgical outcomes collected from medical records. RESULTS: Fifteen CBTs were found in 13 patients and 13 tumors were resected. Selective preoperative tumor embolization was performed on six patients. The median blood loss, operation time, and hospital stay for these patients were not significantly reduced compared to those without embolization. The median tumor size was 2.3 cm in Shamblin I and II and 4 cm in Shamblin III. The median intraoperative blood loss was 280 mL and 700 mL, respectively (P<0.05). Internal carotid artery ligation with reconstruction was accomplished on three patients (23%), and they all belonged to Shamblin III (38%). One Shamblin III patient (8%) developed transient cerebral ischemia, and postoperative stroke with death occurred in another Shamblin III patient. Postoperative permanent cranial nerve deficit occurred in three patients (23%) who were all in Shamblin III (P=0.03). There were no recurrences or delayed complications at the median follow up of 29 months. CONCLUSION: Shamblin III had a high risk of postoperative neurovascular complications. Therefore, early detection and prompt surgical resection of CBTs will decrease surgical morbidity.
